Hot Keywords
Tumor Microenvironment Exosomes and Extracellular Vesicles Breast Cancer Metastasis Bone Metastasis Metastatic Renal Cell Carcinoma Lymph node metastasis Mesothelioma Hematological Malignancies Thyroid Cancer Liquid Biopsies Early Diagnosis Lung Cancer Brain Tumors Lymphoma Oncolytic Virus Cervical Cancer Cancer Stem Cells

Top
The paper's citation list
No.The paper's citation list
1Polymeric and Natural Composites. 2022;299 doi: 10.1007/978-3-030-70266-3_10
2The interactive effect of amlodipine and chemotherapeutic agents in lung cancer cells. 2022;32:101066 doi: 10.1016/j.imu.2022.101066
3Protein Kinases - Promising Targets for Anticancer Drug Research. 2021;24: doi: 10.5772/intechopen.99070
4Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer. 2020;10: doi: 10.3389/fonc.2020.00992
5Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential. 2019;9:174 doi: 10.3390/biom9050174
6Targeted Nanomedicine for Breast Cancer Therapy. 2022;111 doi: 10.1016/B978-0-12-824476-0.00007-3
7Receptor Tyrosine Kinases. 2020;147:319 doi: 10.1016/bs.acr.2020.04.008
8Interplay between Cell Death and Cell Proliferation Reveals New Strategies for Cancer Therapy. 2022;23:4723 doi: 10.3390/ijms23094723
9Steering the antitumor drug discovery campaign towards structurally diverse indolines. 2020;94:103436 doi: 10.1016/j.bioorg.2019.103436
10Molecular Docking of Phytochemicals Targeting GFRs as Therapeutic Sites for Cancer: an In Silico Study. 2022;194:215 doi: 10.1007/s12010-021-03791-7
11Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer. 2019;11:632 doi: 10.3390/cancers11050632
12siRNA-based nanocarriers for targeted drug delivery to control breast cancer. 2022;4:100047 doi: 10.1016/j.adcanc.2022.100047
13Cyclic RGD-Conjugated Hyaluronate Dot Bearing Cleavable Doxorubicin for Multivalent Tumor Targeting. 2020;21:2525 doi: 10.1021/acs.biomac.0c00554
14A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. 2017;12:e0183969 doi: 10.1371/journal.pone.0183969
15Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective. 2020;182:114224 doi: 10.1016/j.bcp.2020.114224
16BCOR Alterations in Pediatric and Young Adult Patients With Sarcomas and High-Grade Glial Malignancies: A Case Series. 2019;1 doi: 10.1200/PO.19.00116
17Histone Deacetylase Inhibitors as Multitarget-Directed Epi-Drugs in Blocking PI3K Oncogenic Signaling: A Polypharmacology Approach. 2020;21:8198 doi: 10.3390/ijms21218198
18Evaluation of the target-specific therapeutic potential of herbal compounds for the treatment of cancer. 2022;26:1823 doi: 10.1007/s11030-021-10271-x
19Neurological Complications of Systemic Cancer and Antineoplastic Therapy. 2022;55 doi: 10.1016/B978-0-12-821976-8.00031-1
20siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways. 2018;6:73 doi: 10.3390/biomedicines6030073
21Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming. 2021;11: doi: 10.3389/fonc.2021.626577
22Expression of VEGF, EGF and HGF in early‑ and late‑stage colorectal cancer. 2021;15: doi: 10.3892/mco.2021.2413
23Computational and In Vitro Approaches to Elucidate the Anti-cancer Effects of Arnica montana in Hormone-Dependent Breast Cancer. 2022; doi: 10.1055/s-0042-1743565
24Metformin in Lung Cancer: Review of in Vitro and in Vivo Animal Studies. 2017;9:45 doi: 10.3390/cancers9050045
25Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance. 2018;33:1 doi: 10.1080/14756366.2017.1370583
26VEGF-and EGF-mediated cooperation of eosinophilic granulocytes and tumor cells in gastric and colon cancer. 2019;18:211 doi: 10.20538/1682-0363-2019-1-211-219
27. ; doi:
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties